We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Doing business with several top 20 Cosmetic giants offering Labskin AI. The contracts will be not just one off payment but multi product, multi year and multi contract based. Also offering Research and Development needs for these Cosmetic and Pharmaceutical giants. Margins for the Labskin service are 80%.
Integumen signs a Cooperative alliance MOU with Innocare Group, Shanghai, China. This will assist commercial enterprises in China with routes to regulatory compliance using Labskin and LabskinAI without the need for animal testing for cosmetics and skincare products.
Laboratory doubled in size in 2019 and again it should double in size again at some point in 2020. That in it self should be a clue where we are heading. That will be a 300% increase.
New offices and Digital Hub opened in Cork, Ireland for IT, AI Infrastructure support and Global Sales.
Sales team only recruited in around End of June 2019 giving only a few months to acquire contracts, Head of Enterprise Sales being Paul Ryan. CIO, Colin O'Sullivan also appointed as CIO and both having a wealth of experience.
3-year revenue sharing Framework with Parity. Integumen will be fulfilling needs for clients that need GDPR, Security, AI and Big Data, Business Tool Software and Mobile Enterprise Resource Solutions . Have access to over 150+ clients in the public and private sector.
Have a 3 year development Remote Automated Water Research project for RAWTest. Watch out for the possible news with MWG as CEO Gerard B joins the board after successful placing from MWG. RAWTest has many other possible applications which can lead to driving additional revenue's.
I million unaudited revenue's for 2019 already in the bag as promised and guided 4 mill for 2020. My personal view point is this may be superseded as it does not include possible Parity partnership and RAWTest revenue's going forward.
Gerard has stated that they will now grow organically. Placing on the 9th Dec 2019 raised £1.368 million as a fail safe for the clients that we have on-board as a reassurance measure.
Integumen who bought out Rinocloud (won the Tech Award 2019 in Ireland), in their own right driving their business forward and may even surpass Labskin revenue's 2:1 as mentioned by GB.
May other services/products provided like Woundcare, CBD Testing, STOER Products for Men etc.
Integumen have so far made the right moves (yes the way the placing was carried out did leave a sour taste but it nearly always does). The Labskin and Intgumen website has information which is worth a view. Do your own research but imo this company could be a monster in the making. In the right sector and already doing business with Multi Billion pound companies.